Colloidal characteristics and formulation of pure protein particulate vaccines

about

Colloidal characteristics and formulation of pure protein particulate vaccines

Item

http://www.wikidata.org/entity/Q57835957

description

im Mai 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 29 May 2012

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2012

@uk

name

Colloidal characteristics and formulation of pure protein particulate vaccines

@en

Colloidal characteristics and formulation of pure protein particulate vaccines

@nl

type

Item

label

Colloidal characteristics and formulation of pure protein particulate vaccines

@en

Colloidal characteristics and formulation of pure protein particulate vaccines

@nl

prefLabel

Colloidal characteristics and formulation of pure protein particulate vaccines

@en

Colloidal characteristics and formulation of pure protein particulate vaccines

@nl

P1476

Colloidal characteristics and formulation of pure protein particulate vaccines

@en

P2093

Linda Sze Tu

http://www.w3.org/2001/XMLSchema#string

Pascal Hickey

http://www.w3.org/2001/XMLSchema#string

Paul J White

http://www.w3.org/2001/XMLSchema#string

P2860

Saponin-adjuvanted particulate vaccines for clinical use.

ISCOM-based vaccines: the second decade.

Pathogen recognition and development of particulate vaccines: does size matter?

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.

Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity.

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.

P304

1386-1393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.2042-7158.2012.01513.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22943169

http://www.w3.org/2001/XMLSchema#string